Where is BTG going?
BTG is building leading positions in the fast-growing area of Interventional Medicine therapies. We have the strategy, resources and capabilities to achieve our vision.
I am pleased to introduce this year’s Annual Report, in what has been a year of significant strategic progress for our business. BTG is now recognised as a leading provider of innovative, image-guided minimally invasive technologies by specialist physicians who are striving to improve patient outcomes.
A strategy for success
Demand for cost-effective treatments, supported by advances in imaging and device technology, continues to fuel the development and application of minimally invasive procedures. BTG is well positioned to take advantage of these macro trends in healthcare. We specialise in areas of therapy where physicians and their patients are poorly served by existing treatments, and where we can develop market-leading positions by delivering differentiated products that demonstrate clinical and commercial value.
People and culture
BTG is a dynamic business, composed of talented individuals who are dedicated to delivering important products that make a real difference to our customers and their patients. I would like to thank our employees for their professionalism and hard work. We will continue to invest in enhancing our capabilities and systems to meet the needs of our stakeholders in a sustainable and responsible way.
BTG has an exciting future ahead of it. I am optimistic about the opportunities in Interventional Medicine and confident that our strategy will enable us to become leaders in the field. As a financially strong business, we have the ability to invest in multiple growth drivers that will create long-term, sustained value for all our stakeholders.
By delivering products that improve patient treatment, and that are valued by clinicians and payers, we will grow our business sustainably and deliver significant value to all our stakeholders.Read more